Delivery Order SPE2DB22D3019-SPE2DB22FK3FD
Award Date
8/17/22
Potential Completion Date
8/18/22
Potential Value
$90K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of VASCEPA 1 GM CAPSULE 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order. The contract, with a ceiling value of $7,117.17, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award is for the delivery of VASCEPA 1 GM CAPSULE 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $11,707.33 firm fixed-price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM). The contract has an ultimate completion date of March 14, 2024 and is not designated as a set-aside. Amerisourcebergen...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $32,821.65 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of VASCEPA 1 GM CAPSULE 120S. This contract has a completion date of May 4, 2023 and uses a firm fixed price pricing type. The award was made without any set-aside designations, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Vascepa 1 GM Capsule 120S, a pharmaceutical product. The contract, valued at $3,753.52, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of October 19, 2023. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $1,484.08, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of VASCEPA 1 GM CAPSULE 120S, a pharmaceutical product, to support military healthcare programs. The contract has a performance period through May 2, 2024 and is structured as a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $4,567.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VASCEPA 1 GM CAPSULE 120S, a cardiovascular medication. This is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,755.84 firm fixed-price delivery order is for the supply of VASCEPA 1 GM CAPSULE 120S, a cardiovascular medication. The contract has a completion date of December 6, 2022 and was awarded on December 5, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,933.49 firm fixed price delivery order is for the supply of VASCEPA 1 GM capsules. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare...
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $5,922.14 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the supply of VASCEPA 1 GM CAPSULE 120S. The contract has an ultimate completion date of February 9, 2024 and was awarded on February 8, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VASCEPA 1 GM CAPSULE 120S. The $2,214.48 Firm Fixed Price delivery order is a part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., which operates under the Amerisourcebergen brand. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products...